Holen Sie sich die Stockscreener-App
124.91
0.33%
-0.41
Schlusskurs vom Vortag:
$125.32
Offen:
$124.15
24-Stunden-Volumen:
292.70K
Relative Volume:
0.47
Marktkapitalisierung:
$4.04B
Einnahmen:
$747.14M
Nettoeinkommen (Verlust:
$-44.55M
KGV:
-88.54
EPS:
-1.4108
Netto-Cashflow:
$34.52M
1W Leistung:
+3.70%
1M Leistung:
+7.42%
6M Leistung:
-31.46%
1J Leistung:
+23.72%
1-Tages-Spanne:
$123.23
$126.00
1-Wochen-Bereich:
$119.47
$128.12
52-Wochen-Spanne:
$97.16
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Holdings Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
124.91 | 4.05B | 747.14M | -44.55M | 34.52M | -1.4108 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-09-23 | Eingeleitet | Evercore ISI | In-line |
| 2025-08-20 | Eingeleitet | BofA Securities | Buy |
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Holdings Inc Aktie (IRTC) Neueste Nachrichten
iRhythm Discloses AI Cardiac Data at American College of Cardiology - HarianBasis.co
Favorable Zio Results Brighten iRhythm Holdings, Inc (IRTC)’s Prospects - Insider Monkey
Here's why you should retain IRTC stock in your portfolio for now - MSN
Form DEFA14A iRhythm Holdings, Inc. - StreetInsider
iRhythm (NASDAQ: IRTC) seeks approval for 2026 equity plan and director slate - Stock Titan
iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026 - The Manila Times
iRhythm will post Q1 results after market close on April 30 - Stock Titan
IRhythm Holdings, Inc.'s (NASDAQ:IRTC) Path To Profitability - 富途牛牛
Jason H Patten Net Worth (2026) - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Given New $170.00 Price Target at Truist Financial - MarketBeat
Julianne Rodda Net Worth (2026) - GuruFocus
iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results - ADVFN
iRhythm Holdings, Inc. (IRTC) reports $5.6M net income, 70.9% gross margin in Q4 2025 - MSN
A Look At iRhythm Holdings (IRTC) Valuation After New ACC 2026 Clinical And AI Announcements - Sahm
Q4 2025 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
IRTC Should I Buy - Intellectia AI
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Finviz
Goldman Sachs Lowers Price Target for IRTC to $147, Maintains Ne - GuruFocus
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm - marketscreener.com
The Bull Case For iRhythm Holdings (IRTC) Could Change Following New Auditor And AI Zio UpgradeLearn Why - Sahm
IRTC: Evercore ISI Group Lowers Price Target but Maintains Ratin - GuruFocus
iRhythm (IRTC) EVP Julianne Rodda discloses 20,313 shares and RSUs - Stock Titan
iRhythm Holdings (NASDAQ: IRTC) seeks approval for 2026 equity plan, elects nine directors - Stock Titan
How The iRhythm Holdings (IRTC) Narrative Is Shifting With New Guidance And DOJ Overhang - Yahoo Finance
iRhythm Holdings appoints KPMG as new auditor, dismisses PwC By Investing.com - Investing.com Canada
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now - TradingView
iRhythm Holdings, Inc. Files Form 8-K: Company Information, Stock Details, and SEC Filing Data for March 2026 - Minichart
iRhythm Holdings appoints KPMG as new auditor, dismisses PwC - Investing.com
iRhythm (IRTC) switches from PwC to KPMG as independent auditor - Stock Titan
Data Presented at ACC.26 Demonstrate Benefits of iRhythm's Zio Ambulatory ECG Portfolio - National Today
iRhythm Presents Data Demonstrating Zio Ambulatory ECG Benefits Across Patient Populations - National Today
Data presented at ACC.26 further demonstrate the benefits of iRhythm's Zio ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform - Bitget
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform - The Manila Times
Studies found frequent arrhythmias in diabetes, kidney and obesity patients - Stock Titan
Free cash flow per share of iRhythm Holdings, Inc. – LSE:0A7L - TradingView
Does New ACC.26 Data and AI Push Change The Bull Case For iRhythm Holdings (IRTC)? - Sahm
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and iRhythm Technologies (NASDAQ:IRTC) - Defense World
Jason Patten Joins iRhythm Holdings’ Board of Directors - Medical Product Outsourcing
Vanguard lists zero holdings in iRhythm (NASDAQ: IRTC) - Stock Titan
Assenagon Asset Management S.A. Grows Stock Position in iRhythm Technologies $IRTC - MarketBeat
Here’s Artisan Mid Cap Fund’s Updates on iRhythm (IRTC) - msn.com
Q4 Patient Monitoring Earnings Review: First Prize Goes to iRhythm (NASDAQ:IRTC) - Yahoo Finance
[SCHEDULE 13G] iRhythm Holdings, Inc. Passive Investment Disclosure (>5%) - Stock Titan
IRTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Finanzdaten der Irhythm Holdings Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):